Log in
Enquire now
Alpha-9 Theranostics

Alpha-9 Theranostics

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
‌
David Hirsch
CFO
‌
Matthias Jaffe
Crunchbase URL
crunchbase.com/organiz...anostics
Email Address
info@a9oncology.com
Founder
‌
David Perrin
Industry
Biotechnology
Biotechnology
Genetics
Genetics
Life science
Life science
Pharmaceutical industry
Pharmaceutical industry
Investors
Andreessen Horowitz (a16z)
Andreessen Horowitz (a16z)
Delos Capital
Delos Capital
Biotechnology Value Fund
Biotechnology Value Fund
Frazier Healthcare Partners
Frazier Healthcare Partners
Digitalis Ventures
Digitalis Ventures
Aberdeen Asset Management
Aberdeen Asset Management
Latest Funding Round Date
October 23, 2024
Latest Funding Round Amount (USD)
127,750,000
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/alpha9tx
Location
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Canada
Canada
Number of Employees (Ranges)
11 – 50
Phone Number
+17782312500
Total Funding Amount (USD)
127,750,000
Official Website
alpha9tx.com

Find more companies like Alpha-9 Theranostics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.